Salmeterol giver en længerevarende bronkodilatation end konventionelle korttidsvirkende ß2 - agonister, idet bronkodilatationen varer i mindst 12 timer.
Salmeterol produces a longer duration of bronchodilation, lasting for at least 12 hours, than recommended doses of conventional short-acting beta-2-agonists.